Details for New Drug Application (NDA): 064050
✉ Email this page to a colleague
The generic ingredient in CLINDAMYCIN PHOSPHATE is clindamycin phosphate; tretinoin. There are fifty-five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.
Summary for 064050
Tradename: | CLINDAMYCIN PHOSPHATE |
Applicant: | Padagis Us |
Ingredient: | clindamycin phosphate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 064050
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Suppliers and Packaging for NDA: 064050
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLINDAMYCIN PHOSPHATE | clindamycin phosphate | SOLUTION;TOPICAL | 064050 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-562 | 45802-562-01 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (45802-562-01) / 30 mL in 1 BOTTLE, WITH APPLICATOR |
CLINDAMYCIN PHOSPHATE | clindamycin phosphate | SOLUTION;TOPICAL | 064050 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-562 | 45802-562-02 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (45802-562-02) / 60 mL in 1 BOTTLE, WITH APPLICATOR |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | EQ 1% BASE | ||||
Approval Date: | Nov 30, 1995 | TE: | AT | RLD: | No |
Complete Access Available with Subscription